Truveris Announces Pharmacy Expert “Center of Excellence”

Audio By Carbonatix

WILMINGTON, Del.--(BUSINESS WIRE)--Mar 31, 2026--

Truveris, an independent pharmacy cost containment company, today announced the formal launch of their Center of Excellence, a cross-functional team of pharmacy industry and benefits experts specializing in clinical strategy, PBM contract procurement and oversight, data analytics, and other pharmacy-related areas. The Center of Excellence is designed to strengthen benefits decisions, cost containment strategies, and outcomes for all Truveris partners and clients.

As pharmacy costs rapidly increase and plan designs grow more complex, plan sponsors and benefits consultants need trusted expert interpretation, an independent perspective, and strategic guidance. The Center of Excellence directly supports Truveris’ ongoing contract procurement, claims oversight, and advisory work by interpreting pharmacy contract language, evaluating new clinical programs, and proactively addressing policy and market shifts, delivering guidance that drives measurable performance improvement.

“Now more than ever, we’re seeing the importance of having a wide range of pharmacy expertise available to help manage pharmacy costs,” said Louise Shea, RPh, Chief Pharmacy Officer at Truveris and lead of the Center of Excellence.

“Our Center of Excellence reflects Truveris’ commitment and focus to helping partners navigate real challenges in pharmacy benefit design and spend through a proactive and consultative approach.”

Enhancing Pharmacy Cost Containment Support in a Rapidly Changing Landscape

Already in 2026, Truveris’ Center of Excellence, comprised of PharmDs and analytical experts, has played a critical role in supporting clients’ plan challenges and producing timely educational insights. The team has guided partners through major industry developments including GLP‑1 and biosimilar utilization, direct‑to‑consumer purchasing trends, legislative changes, new PBM policies, and other market dynamics, such as TrumpRx and the ESI/FTC settlement.

“Pharmacy costs remain one of the most complex and material drivers of benefit spend,” said Garrett Fienberg, Chief Executive Officer at Truveris.

“The Center of Excellence represents a deliberate investment in deeper clinical, contracting, and analytical expertise so our partners can navigate change and act with confidence.”

The Center of Excellence collaborates across Truveris to inform competitive PBM contract procurements and translate insights from ongoing claims oversight into clear, actionable, and practical guidance for partners.

About Truveris

Truveris is a Pharmacy Cost Containment (PCC) company dedicated to reducing pharmacy costs and driving transparency for employers and benefit consultants. Our proprietary, data-driven technology and industry expertise empower smarter pharmacy benefit decisions through contract optimization and PBM oversight. For more, visit www.truveris.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260331772793/en/

CONTACT: Media Contact

Andres Berrios

[email protected]

KEYWORD: DELAWARE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: GENERAL HEALTH PROFESSIONAL SERVICES HEALTH HUMAN RESOURCES

SOURCE: Truveris

Copyright Business Wire 2026.

PUB: 03/31/2026 09:30 AM/DISC: 03/31/2026 09:30 AM

http://www.businesswire.com/news/home/20260331772793/en